Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SRPT
Stock Latest News
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference
3d ago
BNTC
CRSP
Premium
The Fly
New Sarepta label weakens commercial narrative, says H.C. Wainwright
4d ago
SRPT
Premium
Ratings
Cautious Hold Rating on Sarepta Therapeutics Amid Elevidys Label Updates and Safety Concerns
6d ago
SRPT
Premium
Ratings
Sell Rating for Sarepta Therapeutics Amid Label Changes and Market Challenges
6d ago
SRPT
Premium
The Fly
Sarepta confirms FDA approval of updated Elevidys prescribing information
7d ago
SRPT
Premium
The Fly
Sarepta up 9% after FDA approves new warning label for Elevidys
7d ago
SRPT
Premium
The Fly
FDA approves new safety warning and revised indication for Sarepta’s Elevidys
7d ago
SRPT
Premium
The Fly
FDA appoints Richard Pazdur as Director of CDER
10d ago
AZN
BMY
Premium
The Fly
Wave Life Sciences price target lowered to $16 from $18 at Wells Fargo
10d ago
WVE
SRPT
Premium
The Fly
Sarepta price target lowered to $20 from $22 at Barclays
16d ago
SRPT
Premium
The Fly
Sarepta upgraded to Outperform from Neutral at Mizuho
16d ago
SRPT
Premium
Company Announcements
Sarepta Therapeutics’ Earnings Call: Revenue Resilience Amid Challenges
17d ago
SRPT
Premium
Ratings
Mixed Financial Signals and Future Revenue Concerns Lead to Hold Rating for Sarepta Therapeutics
17d ago
SRPT
Premium
Market News
Sarepta Stock’s (SRPT) Painful Plunge! Is There Any Hope Left for Investors after DMD Trial Miss?
17d ago
SRPT
Premium
The Fly
Midday Fly By: Palantir reports Q3 beat, Starbucks forms China JV
17d ago
CZR
HTZ
Premium
The Fly
Sarepta falls -33.5%
17d ago
SRPT
Premium
The Fly
Sarepta price target lowered to $15 from $21 at Baird
17d ago
SRPT
Premium
The Fly
Sarepta falls -30.9%
17d ago
SRPT
Premium
The Fly
Video: Palantir, Uber slip after earnings
17d ago
NSP
YUM
Premium
Ratings
Sell Rating for Sarepta Therapeutics Amid ESSENCE Study Disappointment and Reimbursement Concerns
17d ago
SRPT
Premium
Company Announcements
Sarepta Therapeutics Reports Q3 2025 Financial Results
17d ago
SRPT
Premium
The Fly
Closing Bell Movers: Palantir down 3% after earnings
18d ago
FN
GT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
